INJUNCTION SOUGHT OVER GENERIC ALLEGRA

Sanofi-Aventis and partner Albany Molecular Research have filed a motion in federal court to prevent several drugmakers from marketing generic versions of top-selling allergy drug Allegra. The injunction, filed in a U.S. district court in New Jersey, seeks to block generic Allegra products proposed by Barr Pharmaceuticals (BRL: news, chart, profile) , Teva Pharmaceutical Industries (TEVA: news, chart, profile), Ranbaxy Laboratories and Amino Chemicals.

MarketWatch (http://www.marketwatch.com/news/story.asp?guid=%7B6984F200-90E1-4449-A740-EFA899BD8C1D%7D&siteid=google)